Cargando…

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)

BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-man...

Descripción completa

Detalles Bibliográficos
Autores principales: Roelofsen, Yvonne, Hendriks, Steven H, Sieverink, Floor, van Vugt, Michael, van Hateren, Kornelis JJ, Snoek, Frank J, de Wit, Maartje, Gans, Rijk OB, Groenier, Klaas H, van Gemert-Pijnen, Julia EWC, Kleefstra, Nanne, Bilo, Henk JG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016215/
https://www.ncbi.nlm.nih.gov/pubmed/24593656
http://dx.doi.org/10.1186/1472-6823-14-22
_version_ 1782315469326254080
author Roelofsen, Yvonne
Hendriks, Steven H
Sieverink, Floor
van Vugt, Michael
van Hateren, Kornelis JJ
Snoek, Frank J
de Wit, Maartje
Gans, Rijk OB
Groenier, Klaas H
van Gemert-Pijnen, Julia EWC
Kleefstra, Nanne
Bilo, Henk JG
author_facet Roelofsen, Yvonne
Hendriks, Steven H
Sieverink, Floor
van Vugt, Michael
van Hateren, Kornelis JJ
Snoek, Frank J
de Wit, Maartje
Gans, Rijk OB
Groenier, Klaas H
van Gemert-Pijnen, Julia EWC
Kleefstra, Nanne
Bilo, Henk JG
author_sort Roelofsen, Yvonne
collection PubMed
description BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-management and reduce the burden on the healthcare system. METHODS: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed. DISCUSSION: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population. TRIAL REGISTRATION: Trial registration: NCT01570140.
format Online
Article
Text
id pubmed-4016215
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40162152014-05-10 Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40) Roelofsen, Yvonne Hendriks, Steven H Sieverink, Floor van Vugt, Michael van Hateren, Kornelis JJ Snoek, Frank J de Wit, Maartje Gans, Rijk OB Groenier, Klaas H van Gemert-Pijnen, Julia EWC Kleefstra, Nanne Bilo, Henk JG BMC Endocr Disord Study Protocol BACKGROUND: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients’ self-management and reduce the burden on the healthcare system. METHODS: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed. DISCUSSION: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population. TRIAL REGISTRATION: Trial registration: NCT01570140. BioMed Central 2014-03-04 /pmc/articles/PMC4016215/ /pubmed/24593656 http://dx.doi.org/10.1186/1472-6823-14-22 Text en Copyright © 2014 Roelofsen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Roelofsen, Yvonne
Hendriks, Steven H
Sieverink, Floor
van Vugt, Michael
van Hateren, Kornelis JJ
Snoek, Frank J
de Wit, Maartje
Gans, Rijk OB
Groenier, Klaas H
van Gemert-Pijnen, Julia EWC
Kleefstra, Nanne
Bilo, Henk JG
Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title_full Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title_fullStr Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title_full_unstemmed Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title_short Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
title_sort design of the e-vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-vitadm-1/zodiac-40)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016215/
https://www.ncbi.nlm.nih.gov/pubmed/24593656
http://dx.doi.org/10.1186/1472-6823-14-22
work_keys_str_mv AT roelofsenyvonne designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT hendriksstevenh designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT sieverinkfloor designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT vanvugtmichael designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT vanhaterenkornelisjj designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT snoekfrankj designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT dewitmaartje designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT gansrijkob designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT groenierklaash designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT vangemertpijnenjuliaewc designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT kleefstrananne designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40
AT bilohenkjg designoftheevitadiabetesmellitusstudyeffectsanduseofaninteractiveonlinecareplatforminpatientswithtype2diabetesevitadm1zodiac40